What is the recommended diagnostic approach for ulcerative colitis?

Diagnosing Ulcerative Colitis

The diagnosis of ulcerative colitis requires colonoscopy with histology, supported by clinical history, elevated inflammatory markers (CRP, faecal calprotectin), and exclusion of infection 1.

Diagnostic Algorithm

Initial Assessment in Primary/Secondary Care

When a patient presents with suggestive symptoms (bloody diarrhea, urgency, tenesmus):

1. Blood tests: Full blood count, CRP, albumin
2. Stool studies:
   • Exclude infection (bacterial culture, C. difficile, parasites)
   • Faecal calprotectin (excellent sensitivity but poor specificity for IBD) 1
3. Proceed to endoscopy if inflammatory markers elevated and infection excluded

Endoscopic Evaluation - The Gold Standard

For stable presentations:

• Full colonoscopy with intubation of terminal ileum 1, 2
• Minimum biopsy protocol: At least 2 biopsies from 5 sites (rectum, sigmoid, descending colon, transverse colon, ascending colon) plus terminal ileum 2
• Biopsies must be accompanied by clinical information including symptom duration and current medications 2

For acute severe colitis presentations:

• Unprepared flexible sigmoidoscopy during acute phase
• Planned colonoscopy later to assess full disease extent 1

Key Endoscopic Features

Ulcerative colitis characteristically shows:

• Continuous inflammation starting at the anal verge, extending proximally
• Clear demarcation between inflamed and normal mucosa (transition occurs abruptly within millimeters)
• Mucosal friability, spontaneous bleeding, ulcerations in severe disease 2

Histological Diagnosis

Early disease (within 2 weeks of symptoms):

• Basal plasmacytosis is the earliest and most predictive feature 2
• Preserved crypt architecture does NOT rule out UC at this stage
• Only 20% show crypt distortion within 2 weeks 2
• Consider repeat biopsies if initial findings inconclusive

Established disease:

• Crypt architectural distortion and mucosal atrophy
• Diffuse transmucosal inflammatory infiltrate with basal plasmacytosis
• Active inflammation with cryptitis and crypt abscesses 2
• Decreasing gradient of inflammation from distal to proximal (distinguishes from Crohn's) 2

Disease Extent Classification

Use Montreal classification (adults) to determine:

• Proctitis: Limited to rectum
• Left-sided colitis: Up to splenic flexure
• Extensive colitis: Beyond splenic flexure

Clinical importance: Extent determines prognosis and colectomy risk:

• Extensive colitis: 19% 10-year colectomy rate
• Left-sided: 8%
• Proctitis: 5% 1

Adjunctive Imaging

For acute presentations or complications:

• Abdominal X-ray, CT, or ultrasound to define extent and exclude toxic megacolon 1
• Not required for routine diagnosis

Critical Pitfalls to Avoid

1. Do not rely on faecal calprotectin alone - infections and drugs also elevate it 1
2. Do not skip ileal biopsies - needed to exclude Crohn's disease 2
3. Do not diagnose without histology - endoscopic appearance alone is insufficient 1
4. In treated patients, be aware that therapy alters the classical distribution pattern 2
5. Endoscopic appearance may underestimate extent in quiescent disease - segmental biopsies are essential 1

When Diagnosis Remains Uncertain

• Repeat colonoscopy with biopsies after interval (weeks to months)
• Additional histological features develop over time that clarify diagnosis 2
• Consider inflammatory bowel disease unclassified (IBDU) as temporary designation until definitive features emerge

The 2025 British Society of Gastroenterology guidelines 1 represent the most current evidence, reinforcing that diagnosis ultimately rests on the combination of endoscopic evaluation and histological assessment, with clinical and laboratory findings serving as supportive but not definitive criteria.